As the COVID-19 pandemic enters into its 18-month mark, the global race for novel therapeutics blazes on, with international guidelines being updated to include new therapeutic agents by the flurried month.
Relative to other countries, the face of the pandemic locally . . .
Sign Up or Log In as a healthcare professional to read the full article.